The Biden administration has put the finishing touches on the steps entities covered under the 340B Drug Discount Program must take to resolve disputes with drug manufacturers. The final rule, issued ...

The Tungsten+PLUS™ platform delivers comprehensive downstream services, including MFP claims reconciliation, dispute resolution, and compliance-ready workflows. The platform provides Health Systems ...

HHS has finalized a rule to establish a 340B administrative dispute resolution process as required under the Affordable Care Act. The ADR process allows all 340B-covered entities — regardless of the ...

HHS wants to adjust how disputes about overcharging, duplicate discounts and diversions part of the 340B program are handled, according to a notice posted on the American Hospital Association’s ...

Providers and drugmakers are once again at odds over the 340B drug discount program: this time, over a rule finalized by the Biden administration on Thursday making changes to its dispute resolution ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The American Hospital Association's initial comment on the Health Resources and Services Administration’s (HRSA) request for information regarding a 340B Rebate Model Pilot Program.

Only a week after calling it quits on a court-halted pilot program, the Trump administration is already revving the engine on how it could test out a rebate model for the 340B Drug Discount program | ...

Sagebrush Health Services has filed a lawsuit in California state court accusing Amgen of unlawfully cutting off 340B discounted drug sales to its Nevada clinics and reclaiming at least US$7,000,000 ...